Impact of a Bladder Cancer Diagnosis on Smoking Behavior
- 20 May 2012
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 30 (15) , 1871-1878
Abstract
Purpose: Bladder cancer is the second most common tobacco-related malignancy. A new bladder cancer diagnosis may be an opportunity to imprint smoking cessation. Little is known about the impact of a diagnosis of bladder cancer on patterns of tobacco use and smoking cessation among patients with incident bladder cancer. Patients and Methods: A simple random sample of noninvasive bladder cancer survivors diagnosed in 2006 was obtained from the California Cancer Registry. Respondents completed a survey on history of tobacco use, beliefs regarding bladder cancer risk factors, and physician influence on tobacco cessation. Respondents were compared by smoking status. Those respondents smoking at diagnosis were compared with general population controls obtained from the California Tobacco Survey to determine the impact of a diagnosis of bladder cancer on patterns of tobacco use. Results: The response rate was 70% (344 of 492 eligible participants). Most respondents (74%) had a history of cigarette use. Seventeen percent of all respondents were smoking at diagnosis. Smokers with a new diagnosis of bladder cancer were almost five times as likely to quit smoking as smokers in the general population (48% v 10%, respectively; P < .001). The bladder cancer diagnosis and the advice of the urologist were the reasons cited most often for cessation. Respondents were more likely to endorse smoking as a risk factor for bladder cancer when the urologist was the source of their understanding. Conclusion: The diagnosis of bladder cancer is an opportunity for smoking cessation. Urologists can play an integral role in affecting the patterns of tobacco use of those newly diagnosed.Keywords
This publication has 59 references indexed in Scilit:
- Dietary Antioxidant Intake in Patients at Risk for Second Primary CancerThe Laryngoscope, 2003
- Health perceptions and risk behaviors of lung cancer survivorsHeart & Lung, 2003
- Brief Physician-Initiated Quit-Smoking Strategies for Clinical Oncology Settings: A Trial Coordinated by the Eastern Cooperative Oncology GroupJournal of Clinical Oncology, 2003
- Effect of smoking, alcohol, and depression on the quality of life of head and neck cancer patientsGeneral Hospital Psychiatry, 2002
- Factors associated with smoking and alcohol consumption following treatment for head and neck cancerOral Oncology, 2001
- Smoking withdrawal and relapse in head and neck cancer patientsHead & Neck, 1999
- Factors Affecting Smoking Cessation in Patients With Head and Neck CancerThe Laryngoscope, 1997
- Smoking Cessation and Lung Cancer ResectionChest, 1996
- Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancerCancer, 1995
- Smoking behavior following diagnosis in patients with Stage I non-small cell lung cancerCancer Causes & Control, 1991